Nordic Nanovector ASA announced that Jostein Dahle, chief scientific officer and co-founder, leaves the company. Together with Roy Hartvig Larsen and Ãyvind Sverre Bruland, Jostein Dahle established Nordic Nanovector in 2009.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.056 NOK | +2.52% | -2.22% | -18.14% |
Feb. 28 | Transcript : Thor Medical ASA, H2 2023 Earnings Call, Feb 28, 2024 | |
Feb. 14 | Thor Medical ASA Announces CEO Changes | CI |
1st Jan change | Capi. | |
---|---|---|
-18.14% | 21.9M | |
-1.21% | 103B | |
+8.05% | 101B | |
+4.40% | 23.07B | |
-12.35% | 22.23B | |
-4.36% | 18.05B | |
-39.98% | 17.18B | |
-10.84% | 16.94B | |
+6.80% | 14.07B | |
+38.53% | 12.35B |
- Stock Market
- Equities
- NANOV Stock
- News Thor Medical
- Nordic Nanovector ASA Announces Resignation of Jostein Dahle, Chief Scientific Officer and Co-Founder